Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Translarna
Translarna
PTC Therapeutics Faces Setback on Translarna Approval
Tip Ranks
Fri, 10/18/24 - 11:31 am
PTC Therapeutics
EMA
Europe
Translarna
Duchenne Muscular Dystrophy
3rd time's the charm? PTC will get another chance to keep Translarna's European marketing authorization
Fierce Pharma
Mon, 05/20/24 - 05:46 pm
PTC Therapeutics
Translarna
Europe
PTC's re-examination bid for DMD drug Translarna falls short in Europe
Fierce Pharma
Fri, 01/26/24 - 11:10 am
PTC Therapeutics
EMA
Europe
Translarna
DMD
PTC deepens layoffs as DMD drug faces loss of authorization across Europe
Fierce Biotech
Fri, 09/29/23 - 10:19 am
PTC Therapeutics
DMD
layoffs
Europe
Translarna
After FDA setback, PTC Therapeutics' DMD drug Translarna faces possible market withdrawal in Europe
Fierce Pharma
Fri, 09/15/23 - 11:49 am
PTC Therapeutics
DMD
Translarna
Europe
PTC Ready to Take Another Shot at FDA Approval of DMD Drug
BioSpace
Tue, 06/21/22 - 10:58 am
PTC Therapeutics
Translarna
FDA
Duchenne Muscular Dystrophy
PTC aims again for FDA review of Duchenne drug despite latest miss
BioPharma Dive
Sat, 02/6/21 - 11:10 pm
PTC Therapeutics
Translarna
Duchenne Muscular Dystrophy
FDA
Why PTC Therapeutics Dropped 30.6% Today After Jumping 27.5% Yesterday
Motley Fool
Tue, 06/19/18 - 10:42 pm
PTC Therapeutics
risdiplam
Biogen
Ionis Pharmaceuticals
spinal muscular atrophy
Sarepta Therapeutics
Translarna
Emflaza
No Charm: PTC’s Duchenne Drug Rejected by FDA for Third Time
Xconomy
Thu, 10/26/17 - 09:25 am
PTC Therapeutics
Duchenne Muscular Dystrophy
FDA
Translarna
Duchenne muscular dystrophy
Motley Fool
Thu, 09/21/17 - 10:10 pm
Duchenne Muscular Dystrophy
PTC Therapeutics
Translarna
Axovant Sciences
Alzheimer's disease
NASH
Gilead Sciences
Key FDA Regulatory Events to Watch Out for in Sep 2017
Yahoo/Zacks.com
Mon, 09/4/17 - 10:31 pm
FDA
Mylan Labs
Herceptin
biosimilars
trastuzumab
Shingrix
GSK
Pfizer
Sutent
PTC Therapeutics
Translarna
Amgen
Allergan
Avastin
3 Biotech Stocks That Could Soar in September
Motley Fool
Sun, 08/27/17 - 06:26 pm
biotech
fitusiran
Alnylam
PTC Therapeutics
Translarna
Sarepta
Exondys 51
Bad News Biotechs: What's Next for Juno and PTC Therapeutics?
Motley Fool
Mon, 03/6/17 - 09:40 am
Juno Therapeutics
PTC Therapeutics
CAR-T
Celgene
cystic fibrosis
Translarna
PTC shares plunge anew after FDA slaps down Duchenne drug for a second time
Endpoints
Mon, 10/17/16 - 11:46 pm
PTC Therapeutics
FDA
Duchenne Muscular Dystrophy
Translarna
Duchenne drug rejected in US is available in England
Pharma Times
Fri, 07/8/16 - 10:16 am
Duchenne Muscular Dystrophy
England
PTC Therapeutics
Translarna
PTC Therapeutics Drug Doesn't Meet Goal in Duchenne Trial
Bloomberg
Fri, 10/16/15 - 06:59 am
PTC Therapeutics
Duchenne Muscular Dystrophy
clinical trials
Translarna
3 Drugmakers Facing a Pivotal 2015
Motley Fool
Mon, 12/22/14 - 01:12 pm
PTC Therapeutics
Translarna
GW Pharma
Isis Pharmaceuticals
Pfizer bets on Duchenne MD treatment
Medical Marketing and Media
Thu, 12/18/14 - 04:30 pm
Pfizer
Duchenne Muscular Dystrophy
Translarna
Why a bigger deal hasn't been made of the world's first approval of a Duchenne drug
Bizjournals.com
Thu, 08/7/14 - 09:45 am
Duchenne Muscular Dystrophy
drug approvals
PTC Therapeutics
Translarna
Surprising Drug Approval: Time to Buy? (video)
Motley Fool
Sun, 06/1/14 - 11:26 am
multiple sclerosis
MS
PTC Therapeutics
Translarna